Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas | Nature Portfolio Health Community
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas's Page – iACToR
Interviews - Trinity Development & Alumni - Trinity College Dublin
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas presentations | SlideShare
Greek Researcher Receives Top European Innovation Award (video)
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia: 9781466682344: Medicine & Health Science Books @ Amazon.com
Interview with venture case winner Alterniity: We didn't fly too high or too low”
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
TGL2019 - Dr. Ioannis Tarnanas - YouTube
Ioannis Tarnanas (@ITarnanas) / Twitter
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
